Somatosensory Evoked Potentials From the Lower Urinary Tract

July 30, 2025 updated by: Swiss Paraplegic Research, Nottwil

Somatosensory Evoked Potentials From the Lower Urinary Tract in Individuals With Neurogenic Lower Urinary Tract Dysfunction as a Result of Spinal Cord Injury

Spinal cord injury and other systemic neurological diseases (Multiple Sclerosis, Parkinson's disease) affect the integrity of lower urinary tract (LUT) function, leading to neurogenic lower urinary tract dysfunction (NLUTD). The urodynamic investigation is the current "gold-standard" for evaluating LUT function. Nevertheless, the sensory situation of the LUT cannot be investigated objectively. Furthermore, the current classification of the severity of the NLUTD due to spinal cord injury (SCI) does not represent the sensory situation of the LUT. Additional investigations therefore need to be established for assessing the sensory situation of the LUT. Somatosensory evoked potentials (SEPs) are an established method for investigating the processing of sensory nervous activity. However, SEPs from the LUT of SCI individuals have not yet been investigated.

A novel technique, i.e. diffusion tensor imaging (DTI), allows to process magnetic resonance images (MRI) in order to visualize nerve fibers. Using DTI, the innervation of the bladder after SCI can be visualized. The structural presentation of bladder innervation will be compared with the functional results, i.e. the SEP of the LUT in SCI individuals.

The primary objective of the proposed study is to elicit and characterize (latency, amplitude) the somatosensory evoked potentials (SEPs) from the bladder in individuals suffering from neurogenic lower urinary tract dysfunction as a result of spinal cord injury.

Furthermore, the SEPs from the bladder will be compared with the SEPs from peripheral nerves (N. tibialis, N. pudendus, N. medianus).

Moreover, the latency and amplitude of the SEPs from the bladder of individuals with somato-sensory complete spinal cord injury will be compared with those from the bladder of individuals with somato-sensory incomplete spinal cord injury.

Finally, the structural innervation of the bladder after SCI will be compared with the remaining sensory function.

Study Overview

Status

Withdrawn

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • LU
      • Nottwil, LU, Switzerland, CH-6207
        • Swiss Paraplegic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

individuals with neurogenic lower urinary tract dysfunction as a result of spinal cord injury

Description

Inclusion Criteria:

  • Informed Consent as documented by signature
  • Chronic SCI of a minimum of 1 year
  • Aetiology of SCI: traumatic

Exclusion Criteria:

  • Age < 18 years or > 70 years
  • Aetiology of SCI: non-traumatic
  • History of bleeding disorder
  • History of chronic neuropathic pain
  • Intravesical botulinum toxin injections < 12 months ago
  • Bladder management using indwelling catheters (suprapubic, transurethral)
  • Bladder augmentation
  • Sacral deafferentation
  • Sacral neuromodulation
  • Acute, symptomatic urinary tract infection
  • Pregnancy
  • Urolithiasis
  • Bladder cancer
  • Exclusion criteria for MRI (cardiac pace maker, implanted metal etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
complete
individuals with somato-sensory complete spinal cord injury
incomplete
individuals with somato-sensory incomplete spinal cord injury

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
occurrence of somatosensory evoked potentials from the bladder
Time Frame: within 1 week after enrollment into study
within 1 week after enrollment into study

Secondary Outcome Measures

Outcome Measure
Time Frame
latency of somatosensory evoked potentials
Time Frame: within 1 week after enrollment into study
within 1 week after enrollment into study
peak-to-peak amplitude of somatosensory evoked potentials
Time Frame: within 1 week after enrollment into study
within 1 week after enrollment into study
nerve fiber density around bladder
Time Frame: within 1 week after enrollment into study
within 1 week after enrollment into study
fractional anisotropy of nerve fibers around bladder
Time Frame: within 1 week after enrollment into study
within 1 week after enrollment into study
apparent diffusion coefficient of nerve fibers around bladder
Time Frame: within 1 week after enrollment into study
within 1 week after enrollment into study

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
age
Time Frame: 1st day
1st day
gender
Time Frame: 1st day
1st day
severity of spinal cord injury
Time Frame: 1st day
American Association of Spinal Cord Injury Impairment Score
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jens Wöllner, Swiss Paraplegic Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

May 15, 2015

First Submitted That Met QC Criteria

May 15, 2015

First Posted (Estimated)

May 20, 2015

Study Record Updates

Last Update Posted (Actual)

July 31, 2025

Last Update Submitted That Met QC Criteria

July 30, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2014-20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurogenic Lower Urinary Tract Dysfunction

Subscribe